<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO) produced by murine macrophages is important in murine resistance to ectromelia virus, <z:e sem="disease" ids="C0019348" disease_type="Disease or Syndrome" abbrv="">herpes simplex</z:e> virus, and <z:e sem="disease" ids="C0857841" disease_type="Disease or Syndrome" abbrv="">vaccinia virus infection</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In contrast, NO production by human mononuclear cells has been difficult to demonstrate, and a role for NO in human responses to <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> is uncertain </plain></SENT>
<SENT sid="2" pm="."><plain>We report constitutive, low level, macrophage-type NO synthase (iNOS) expression in Epstein-Barr virus (EBV)-transformed human B lymphocytes and Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines </plain></SENT>
<SENT sid="3" pm="."><plain>Immune NOS activity is involved in maintaining EBV latency through down-regulation of the expression of the immediate-early EBV transactivator Zta </plain></SENT>
<SENT sid="4" pm="."><plain>NO also inhibits <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in B lymphocyte cell lines </plain></SENT>
<SENT sid="5" pm="."><plain>The effects of NO are largely independent of cGMP and influential on signaling pathways regulated by (sulfhydryl) redox status </plain></SENT>
<SENT sid="6" pm="."><plain>These results suggest that NO plays a physiological role in human B cell biology by inhibiting programmed cell <z:hpo ids='HP_0011420'>death</z:hpo> and maintaining <z:mp ids='MP_0001799'>viral</z:mp> latency </plain></SENT>
</text></document>